The prevalence of Mycoplasma genitalium (MG) and Trichomonas vaginalis (TV) at testing centers in Belgium, Germany, Spain, and the UK using the cobas TV/MG molecular assay.

Mycoplasma genitalium (MG) and Trichomonas vaginalis (TV) can lead to long-term sequelae in males and females; however, global prevalence data vary between geographical regions, as these sexually transmitted infections are not included in routine screening. The objective of this study was to use the cobas® TV/MG assay to assess the point prevalence of TV and MG in specimens from men and women over a broad European geographical area. Urine, vaginal, endocervical, and rectal samples were collected from patients aged ≥ 18 years receiving Chlamydia trachomatis (CT) and/or Neisseria gonorrhoeae (NG... Mehr ...

Verfasser: Perry, Michael D
Jones, Sophie
Bertram, Alexander
de Salazar, Adolfo
Barrientos-Durán, Antonio
Schiettekatte, Gilberte
Lewinski, Michael
Arcenas, Rodney
Hansra, Avneet
Njoya, Merlin
García, Federico
Dokumenttyp: research article
Erscheinungsdatum: 2022
Schlagwörter: Molecular diagnostics / Mycoplasma genitalium / PCR / Public health / Trichomonas vaginalis / cobas TV/MG / Humans / Female / Male / Prevalence / Belgium / Spain / Sexually Transmitted Diseases / Chlamydia trachomatis / Neisseria gonorrhoeae / Germany / United Kingdom / Mycoplasma Infections / Gonorrhea / Chlamydia Infections
Sprache: Englisch
Permalink: https://search.fid-benelux.de/Record/base-28953389
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : http://hdl.handle.net/10668/20397

Mycoplasma genitalium (MG) and Trichomonas vaginalis (TV) can lead to long-term sequelae in males and females; however, global prevalence data vary between geographical regions, as these sexually transmitted infections are not included in routine screening. The objective of this study was to use the cobas® TV/MG assay to assess the point prevalence of TV and MG in specimens from men and women over a broad European geographical area. Urine, vaginal, endocervical, and rectal samples were collected from patients aged ≥ 18 years receiving Chlamydia trachomatis (CT) and/or Neisseria gonorrhoeae (NG) screening as per local standard of care at sites in Belgium, Germany, Spain, and the UK (Wales). Remnant samples were assessed using the cobas TV/MG assay. Analysis of 2795 samples showed that MG prevalence varied slightly across female sample types (range: 1.7-5.8%; p = 0.0042). MG prevalence was higher in male rectal samples (12.5%) than in male urine samples (3.9%; p